Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatchell

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Prostate Cancer and Prostatic Diseases|March 1, 2022
Germline alterations among Hispanic men with prostate cancerElizabeth Pan, Justin Shaya, Lisa Madlensky, et al.
JCO Precision Oncology|July 12, 2021
Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline VariantsAnya Mezina, Neil Philips, Zoe Bogus, et al.
JCO Global Oncology|July 22, 2022
Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional StudyCarlos Andrés Ossa Gomez, Maria Isabel Achatz, Mabel Hurtado, et al.
Cell Reports|March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinomaSarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Molecular Genetics & Genomic Medicine|October 17, 2022
Scalable detection of technically challenging variants through modified next-generation sequencingSusan Rojahn, Tina Hambuch, Jessika Adrian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2013
RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulatorsAndrew D Redfern, Shane M Colley, Dianne J Beveridge, et al.
The Journal of Urology|August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate CancerNeal Shore, Christopher Pieczonka, Sean Heron, et al.
Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.
Molecular Cell|June 10, 2006
SLIRP, a small SRA binding protein, is a nuclear receptor corepressorEsme C Hatchell, Shane M Colley, Dianne J Beveridge, et al.
European Urology Oncology|August 13, 2023
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM TrialNeal Shore, Mukaram Gazi, Christopher Pieczonka, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Prostate Cancer and Prostatic Diseases|March 1, 2022
Germline alterations among Hispanic men with prostate cancerElizabeth Pan, Justin Shaya, Lisa Madlensky, et al.
JCO Precision Oncology|July 12, 2021
Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline VariantsAnya Mezina, Neil Philips, Zoe Bogus, et al.
JCO Global Oncology|July 22, 2022
Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional StudyCarlos Andrés Ossa Gomez, Maria Isabel Achatz, Mabel Hurtado, et al.
Cell Reports|March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinomaSarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Molecular Genetics & Genomic Medicine|October 17, 2022
Scalable detection of technically challenging variants through modified next-generation sequencingSusan Rojahn, Tina Hambuch, Jessika Adrian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2013
RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulatorsAndrew D Redfern, Shane M Colley, Dianne J Beveridge, et al.
The Journal of Urology|August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate CancerNeal Shore, Christopher Pieczonka, Sean Heron, et al.
Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.
Molecular Cell|June 10, 2006
SLIRP, a small SRA binding protein, is a nuclear receptor corepressorEsme C Hatchell, Shane M Colley, Dianne J Beveridge, et al.
European Urology Oncology|August 13, 2023
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM TrialNeal Shore, Mukaram Gazi, Christopher Pieczonka, et al.
Pageof 19